Skip to main content

Day: April 26, 2024

Hexatronic Group AB (publ) Interim report January – March 2024

Hexatronic Group AB (publ)Interim report January – March 2024 Continued strong operating cash flow and contribution from new focus areas First quarter (January 1 – March 31, 2024)Net sales decreased by 16 percent to MSEK 1,782 (2,115). Sales decreased organically by 27 percent. EBITA decreased by 54 percent to MSEK 168 (365), corresponding to an EBITA margin of 9.4 percent (17.2). Operating profit (EBIT) decreased by 59 percent to MSEK 138 (340), corresponding to an operating margin of 7.7 percent (16.1). Net profit decreased by 73 percent to MSEK 61 (224). Earnings per share after dilution amounted to SEK 0.31 (1.09). Leverage ratio (net debt/EBITDA (pro forma), R12) amounted to 2.0x compared to 1.7x as of December 31, 2023. Cash flow from operating activities amounted to MSEK 270 (28).Significant events during the quarterThe Board...

Continue reading

JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension

Ad hoc announcement pursuant to Art. 53 LRIdorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive medicinal products. A CHMP positive opinion is one of the final steps before marketing authorization can be granted by the European Commission – a final decision is expected in approximately two months.Allschwil, Switzerland – April 26, 2024Idorsia Ltd (SIX: IDIA) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), adopted a positive opinion for the use of JERAYGO™ (aprocitentan) for the treatment of resistant...

Continue reading

Amundi: First Quarter 2024 Results

Amundi: First Quarter 2024 Results Assets under management at an all-time highHealthy inflows of +€17bn, net income1,2 up +6% Q1/Q1Net income Growth   High level of adjusted net income1,2 Q1 2024: €318m, +5.9% Q1/Q1Driven by the growth of net management fees: +4.0% Q1/Q1 Combined with cost controlCost-income ratio of 53.3%2, at the best level in the industry     High & Diversified Net inflows   Record level assets under management: €2,116bn as of 31 March 2024, +9.4% year-on-year Net inflows Q1 2024: +€16.6bnBalanced by main client segments, expertise and geographies Positive in active management, driven by bond solutions     Continuing Development   Development in line with the priorities of the 2025 Strategic Ambitions plan:Third party Distribution: net inflows +€7bn Passive management: +€5.0bn of...

Continue reading

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 6,000,000 shares of common stock, and (ii) to certain investors, pre-funded warrants to purchase up to an aggregate of 16,000,000 shares of common stock and accompanying common stock warrants to purchase up to an aggregate of 16,000,000 shares of common stock. Each share of common stock and accompanying common stock warrant are being sold together at a combined public offering price of $0.75, and each pre-funded warrant and accompanying common stock warrant are being sold together at a combined public offering price of $0.7499. Each pre-funded warrant will have an exercise...

Continue reading

Valstybės investicinis kapitalas UAB audited Annual information for the year 2023

Valstybės investicinis kapitalas UAB submits approved Financial Statements for the year 2023, prepared according to the International Financial Reporting Standards as adopted by the European Union, together with the Independent Auditor’s Report hereto, as well as the Annual Report. The Company’s shareholder decided on the distribution of profit (losses): the Company’s net profit of the reporting financial year of EUR 18,809,055 added to the undistributed loss of EUR 20,133,062 from the previous financial year and the remaining loss of the Company of EUR 1,324,007 carried forward to the next year. Enclosed:Approved Financial Statements of Valstybės investicinis kapitalas UAB for the year 2023, prepared according to the International Financial Reporting Standards as adopted by the European Union, provided together with the...

Continue reading

Resolutions Adopted at the Annual General Ordinary and Extraordinary Shareholders’ Meeting for Grupo Aeroportuario del Pacifico on April 25, 2024

GUADALAJARA, Mexico, April 25, 2024 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces the following resolutions adopted at the Annual General Ordinary and Extraordinary Shareholders’ Meetings today, with a quorum of 85.01% and 85.14%, respectively: ANNUAL GENERAL ORDINARY SHAREHOLDERS’ MEETING I. In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following were APPROVED:The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2023, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an unconsolidated basis in...

Continue reading

Dominion Lending Centres Inc. Announces Sale of its Interest in Impact Communications

VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSX:DLCG) (“DLCG” or the “Corporation”) is pleased to announce that it has completed a sale of its 52% interest in Cape Communications International Inc. (“Impact”) for aggregate cash proceeds of $3.71 million (the “Purchase Price”) to Impact management (the “Purchaser”). The Corporation will use the cash proceeds from the sale to fully repay its junior term facility. Gary Mauris, Chairman and Chief Executive Officer of the Corporation, commented: “We are pleased to facilitate the sale of our interest in Impact back to management. Keith and Mark have been excellent partners and we wish them much success going forward. The sale marks a significant milestone for the Corporation as Impact was the last remaining asset from the Corporation’s...

Continue reading

Banco Itaú Chile Files Material Event Notice announcing Extraordinary General Shareholders’ Meeting Agreements

SANTIAGO, Chile, April 25, 2024 (GLOBE NEWSWIRE) — BANCO ITAÚ CHILE (SSE: ITAUCL) (the “Company”) announced that it filed today a Material Event Notice with the Chilean Commission for the Financial Market reporting today’s agreements at its extraordinary general shareholders meeting. The Material Event Notice is available on the company’s investor relations website at ir.itau.cl. Investor Relations – Banco Itaú Chile IR@itau.cl / ir.itau.cl

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.